Publication | Closed Access

CSF1R inhibition with emactuzumab in locally advanced diffuse-type tenosynovial giant cell tumours of the soft tissue: a dose-escalation and dose-expansion phase 1 study

MedicineImmunologyPathologySoft TissueImmune Checkpoint InhibitorDose-expansion Phase 1Cancer TreatmentCsf1r InhibitionOncologyRadiation OncologyCancer ResearchTumor Biology